Validation of a population pharmacokinetic model of adalimumab in a cohort of patients with inflammatory bowel disease.
Rev Esp Enferm Dig
; 111(6): 431-436, 2019 Jun.
Article
in En
| MEDLINE
| ID: mdl-31021170
Full text:
1
Database:
MEDLINE
Main subject:
Inflammatory Bowel Diseases
/
Adalimumab
/
Anti-Inflammatory Agents
/
Models, Chemical
Type of study:
Etiology_studies
/
Incidence_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Rev Esp Enferm Dig
Journal subject:
GASTROENTEROLOGIA
Year:
2019
Type:
Article